• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Lymphoma, T-Cell

Lymphoma, T-Cell - 42 Studies Found

Completed : Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
:
  • Lymphoma, T-Cell, Peripheral
  • Lymphoma, T-
    : 2015-09-03
    : Drug: RP6530 Tablet starting at 200 mg Other Name: P
Terminated : CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
: T-cell Lymphoma
: 2009-05-05
:
  • Biological: CHOP + CD4
  • Drug: CHOP

Not yet recruiting : Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients
: Peripheral T Cell Lymphoma
: 2016-11-03
:
  • Drug: chidamide 30mg po twice

Completed : Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
: Peripheral T-cell Lymphomas
: 2015-07-26
:
  • Drug: GDP GDP is a a combinati

Completed : Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
:
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides

: 2014-12-12
:
  • Drug: Methotrexate Methotrexat

Completed : Treatment of Peripheral T-cell Lymphoma
: Peripheral T-cell Lymphoma
: 2012-08-10
:
  • Drug: GDPT regimen GDPT regime

Completed : CHO(E)P-14 Followed by Alemtuzumab Consolidation in Peripheral T Cell Lymphoma
: Peripheral T-Cell Lymphoma
: 2013-02-25
: Drug: Alemtuzumab Consolidation after CHOP induction
Completed : Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma
: Peripheral T-Cell Lymphoma
: 2005-08-26
: Drug: Velcade + ACVBP regimen
Active, not recruiting : A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
: Peripheral T-cell Lymphoma
: 2007-01-23
: Drug: Romidepsin Romidepsin intravenously (through a vein) over 4 hours on Days 1, 8 and 15 of each 28-d
Completed : Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
: Peripheral T-Cell Lymphoma
: 2012-05-30
: Biological: KW-0761 (mogamulizumab) 1 mg/kg administered intravenously weekly x 4 then every other week
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.